Neuralink extends operations to Canada, successfully implementing brain implants in individuals with spinal injuries.

Neuralink Expands Clinical Trials in Canada

Neuralink, the brain-computer interface company founded by Elon Musk, has made a significant stride in its mission to help individuals with spinal cord injuries and neurological disorders. The company's second clinical trial outside the US, the CAN-PRIME Study, has commenced in Canada.

The surgeries, which took place at the University Health Network (UHN) on August 27 and September 3, marked a milestone for Neuralink. The aim is to gather more data on how the system performs in real-life situations.

Recruitment for the CAN-PRIME Study is ongoing, and people with cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS) may be eligible. The study aims to evaluate the implant and surgical robot's safety and determine if people with paralysis can use thought to control external devices.

The impact of the Neuralink implant for patients could be life-changing. It aims to restore some control in daily routines, such as checking emails, interacting on social media, or using smart devices at home. Participants in the CAN-PRIME Study could learn to move a cursor, send a text, or operate a robotic arm.

The Canadian Neuralink trial is led by Dr. Andres Lozano, Alan and Susan Hudson Cornerstone Chair in Neurosurgery at UHN. Dr. Thomas Forbes, Surgeon-in-Chief at UHN, expressed his pride, stating, "We are incredibly proud to be at the forefront of this revolutionary advancement in neurosurgery."

Neuralink, which has already run human trials in the US, is pursuing further regulatory approvals in the U.S. and abroad. The company aims to expand its trials to 20 to 30 participants by the end of 2025.

In addition to helping those with spinal cord injuries, Neuralink is also studying broader applications. These include helping stroke patients regain speech, restoring vision, and potentially allowing people to share or transfer memories and skills.

The research team in Canada applying Neuralink electronic implants in patients with spinal cord injuries is called the "Toronto Neural Interface Group." The technology remains experimental, and safety and reliability must be proven before it can be used more widely. However, the potential benefits for those with neurological disorders are undeniably exciting.